资讯

Oncology Nursing News4 小时
Rx Road Map: Durvalumab for Non-Small Cell Lung Cancer
Durvalumab (Imfinzi) is a PD-L1–blocking antibody that has 3 indications for non–small cell lung cancer (NSCLC). February ...
How Jensen McRae became L.A.'s next great songwriter
On her knockout of a sophomore album, the 27-year-old documents the dissolution of two romantic relationships in gleaming ...